Michael Wacker Investor

Michael Wacker is a seasoned entrepreneur with 20 years of experience in the life science industry. As a General Partner at a Venture Capital Fund, he leverages his expertise to drive success for biotech companies. With a PhD in microbiology from ETH Zurich, he founded GlycoVaxyn, leading it to significant growth and securing over 40m USD in funding. Michael is a prolific author and inventor, with publications in prestigious journals like Science and PNAS. His passion lies in developing innovative vaccines to combat bacterial infections, showcasing his commitment to advancing healthcare.

Invests into